Millennium and Schering-Plough Initiate Clinical Trial With INTEGRILIN (Eptifibatide) Injection in Early Use Acute Coronary Syndrome Setting

Topics:
Healthcare Services
Tags:
Clinical Trial,
Healthcare,
Millennium Pharmaceuticals Inc.,
Schering-Plough Corp.
Source:
Millennium Pharmaceuticals

FREE Registration is required

Overview: In this article Millennium Pharmaceuticals, Inc. and Schering-Plough Corporation discusses the initiation of a multicenter phase IIIb clinical trial to evaluate the benefit of INTEGRILIN when administered early to high-risk patients experiencing non-ST-segment elevation acute coronary syndrome. The trial, known as EARLY ACS (Early Glycoprotein IIb-IIIa Inhibition in Non-ST-segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-loaded Eptifibatide in the Treatment of Patients with Non-ST-segment Elevation Acute Coronary Syndrome) will evaluate the benefit of INTEGRILIN compared to placebo in reducing death and other major adverse cardiac events, including heart attack, within 96 hours and up to 30 days following randomization.

(Is this item miscategorized? Does it need more tags? Let us know.)

Format: HTML | Pages: 3

People who downloaded this item also downloaded

White Paper Bosses: 7 Communication Tips
White Paper Marketing Strategy: 7 Steps to Market Segmentation
White Paper Rescuing Products With Stealth Positioning
Presentation STP--Benefits and Characteristics
Presentation Market Segmentation, Targeting, And Positioning

Top results from Healthcare Services

Resource Center Protect your patient data and your budget at the same time
White Paper New HIPPA Regulations Require Quick Action By Group Health Plans
White Paper A Common Language Architecture for Health Care
White Paper A Digital Imaging Transformation in Radiology Departments
White Paper Alternative Health Care Models

» View all Healthcare Services listings

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Returning users: Log In Here!

Already registered on BNET, TechRepublic, or ZDNet? Simply log in.

Free Membership: Sign Up Now!

Sign up for a free membership today and get instant and unlimited access to one of the largest databases of white papers, webcasts, and casestudies anywhere. Your FREE membership allows you to:

  • Download an unlimited amount of content, including classic and current white papers, case studies, webcasts and more
  • Track content on your chosen topics of interest
  • Receive targeted email alerts when your favorite content is added
  • Save content for future reading
  • Receive our member newsletter

When you register to access this directory, you become a member of BNET. In addition, you allow us to share your information with companies that produce products or services featured in the library--so that such companies may contact you with information and offers regarding their products and services. This enables us to keep the library a free service. As a directory registrant, you will receive a complimentary subscription to the BNET member newsletter, The BNET Report. You can unsubscribe from this newsletter at any time. By clicking the Sign up button, you indicate that you agree to our Terms and Conditions and have read and understand our Privacy Policy (updated).